🤖 AI/ML - ADCs and Therapeutic Index
ADCs (Antibody-Drug Conjugates) are a type of cancer treatment that combines an antibody with a cytotoxic drug. The therapeutic index (TI) is a measure of the ratio of the toxic dose to the effective dose of a drug. Companies are working to widen the TI of ADCs to improve their safety and efficacy.
Key Points:
• ADCs have a narrow therapeutic index, making them challenging to develop.
• Companies are exploring new technologies to widen the TI of ADCs.
• The use of ADCs is increasing in cancer treatment.
🔗 Resources:
• Original source ↗ - Original source
• ADCs ↗ - ADCs and therapeutic index
• ADCs ↗ - ADCs and therapeutic index
• ADCs ↗ - ADCs and therapeutic index
• ADCs ↗ - ADCs and therapeutic index
🤖 AI/ML - Magnetohydrodynamics
Magnetohydrodynamics (MHD) is a field of study that combines magnetism and fluid dynamics. Researchers have developed a formally verified MHD model that preserves hyperbolicity and corrects magnetic divergence errors.
Key Points:
• The MHD model is formally verified and preserves hyperbolicity.
• The model corrects magnetic divergence errors.
• The model is implemented and tested.
🔗 Resources:
• Original source ↗ - Original source
• MHD Model ↗ - MHD model and verification
• MHD Model ↗ - MHD model and verification
• MHD Model ↗ - MHD model and verification
🤖 AI/ML - Ideal MHD
Ideal MHD is a model of magnetohydrodynamics that assumes perfect conductivity and neglects viscosity. Researchers have developed a technical deep dive on ideal MHD, including a corresponding GitHub repository.
Key Points:
• Ideal MHD is a model of magnetohydrodynamics.
• The model assumes perfect conductivity and neglects viscosity.
• The model is implemented and tested.
🔗 Resources:
• Original source ↗ - Original source
• Ideal MHD ↗ - Ideal MHD model and GitHub repository
• Ideal MHD ↗ - Ideal MHD model and GitHub repository
• Ideal MHD ↗ - Ideal MHD model and GitHub repository
• Ideal MHD ↗ - Ideal MHD model and GitHub repository
🤖 AI/ML - OCUDU Lab Testing Services
OCUDU (Open Connectivity and Unified Data Utilization) is a project that aims to develop open standards for connectivity and data utilization. ITRI (Industrial Technology Research Institute) has announced the launch of independent OCUDU lab testing services across the Asia-Pacific region.
Key Points:
• OCUDU is a project that aims to develop open standards for connectivity and data utilization.
• ITRI has launched independent OCUDU lab testing services.
• The services are available across the Asia-Pacific region.
🔗 Resources:
• Original source ↗ - Original source
• OCUDU ↗ - OCUDU project and lab testing services
• OCUDU ↗ - OCUDU project and lab testing services
• OCUDU ↗ - OCUDU project and lab testing services
• OCUDU ↗ - OCUDU project and lab testing services
🤖 AI/ML - Savolitinib and Osimertinib
Savolitinib is a tyrosine kinase inhibitor that is being developed for the treatment of non-small cell lung cancer (NSCLC). A recent study has shown that savolitinib plus osimertinib produced a statistically significant and clinically meaningful improvement in progression-free survival (PFS) compared to osimertinib alone.
Key Points:
• Savolitinib is a tyrosine kinase inhibitor.
• The study showed a statistically significant and clinically meaningful improvement in PFS.
• The combination of savolitinib and osimertinib is being explored as a treatment for NSCLC.
🔗 Resources:
• Original source ↗ - Original source
• Savolitinib ↗ - Savolitinib and osimertinib combination
• Savolitinib ↗ - Savolitinib and osimertinib combination
• Savolitinib ↗ - Savolitinib and osimertinib combination
• Savolitinib ↗ - Savolitinib and osimertinib combination
🤖 AI/ML - Izalontamab Brengitecan
Izalontamab brengitecan is a dual-antibody drug conjugate that is being developed for the treatment of metastatic triple-negative breast cancer (mTNBC). A recent study has shown that izalontamab brengitecan produced a clinically meaningful response in patients with mTNBC.
Key Points:
• Izalontamab brengitecan is a dual-antibody drug conjugate.
• The study showed a clinically meaningful response in patients with mTNBC.
• The treatment is being explored for the treatment of mTNBC.
🔗 Resources:
• Original source ↗ - Original source
• Izalontamab Brengitecan ↗ - Izalontamab brengitecan and mTNBC
• Izalontamab Brengitecan ↗ - Izalontamab brengitecan and mTNBC
• Izalontamab Brengitecan ↗ - Izalontamab brengitecan and mTNBC
• Izalontamab Brengitecan ↗ - Izalontamab brengitecan and mTNBC
🚀 AI/ML - Sword AI Summit
The Sword AI Summit is a conference that brings together experts in artificial intelligence and machine learning. The summit will feature speakers from leading companies in the field, including NVIDIA, Nebius AI, Microsoft, OpenAI, and Google DeepMind.
Key Points:
• The Sword AI Summit is a conference on AI and ML.
• The summit will feature speakers from leading companies in the field.
• The summit will take place on October 3 in Porto.
🔗 Resources:
• Original source ↗ - Original source
• Sword AI Summit ↗ - Sword AI Summit and speakers
• Sword AI Summit ↗ - Sword AI Summit and speakers
• Sword AI Summit ↗ - Sword AI Summit and speakers
• Sword AI Summit ↗ - Sword AI Summit and speakers
• Sword AI Summit ↗ - Sword AI Summit and speakers
• Sword AI Summit ↗ - Sword AI Summit and speakers
• Sword AI Summit ↗ - Sword AI Summit and speakers
• Sword AI Summit ↗ - Sword AI Summit and speakers
• Sword AI Summit ↗ - Sword AI Summit and speakers
🤖 AI/ML - Conflict of Productivity and Ownership
Academic physicians often face a conflict between productivity and ownership. They generate enormous value through publications, personal reputation, referral networks, and clinical revenue, yet often have limited ownership and control over their work.
Key Points:
• Academic physicians face a conflict between productivity and ownership.
• They generate enormous value through various means.
• They often have limited ownership and control over their work.
🔗 Resources:
• Original source ↗ - Original source
• Conflict of Productivity and Ownership ↗ - Conflict of productivity and ownership
• Conflict of Productivity and Ownership ↗ - Conflict of productivity and ownership
• Conflict of Productivity and Ownership ↗ - Conflict of productivity and ownership
• Conflict of Productivity and Ownership ↗ - Conflict of productivity and ownership
🤖 AI/ML - Mission Critical in Pathology
In pathology, "mission critical" refers to the human impact at the end of every system, workflow, and support request. A patient may be waiting for answers, and a potentially life-saving therapy may be moving one step closer to reality.
Key Points:
• "Mission critical" refers to the human impact in pathology.
• A patient may be waiting for answers.
• A potentially life-saving therapy may be moving one step closer to reality.
🔗 Resources:
• Original source ↗ - Original source
• Mission Critical in Pathology ↗ - Mission critical in pathology
• Mission Critical in Pathology ↗ - Mission critical in pathology
• Mission Critical in Pathology ↗ - Mission critical in pathology
🤖 AI/ML - COPERNICUS Study
The COPERNICUS study is a mini oral session at the #WCLC26 conference. The study presents results on the combination of subcutaneous amivantamab and lazertinib with supportive care in EGFR-mutated non-small cell lung cancer (NSCLC).
Key Points:
• The COPERNICUS study is a mini oral session at #WCLC26.
• The study presents results on the combination of subcutaneous amivantamab and lazertinib.
• The combination is being explored for the treatment of EGFR-mutated NSCLC.
🔗 Resources:
• Original source ↗ - Original source
• COPERNICUS Study ↗ - COPERNICUS study and results
• COPERNICUS Study ↗ - COPERNICUS study and results
• COPERNICUS Study ↗ - COPERNICUS study and results
• COPERNICUS Study ↗ - COPERNICUS study and results
